For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
How has the psychosis grown historically, and what trends indicate future expansion?
The psychosis market size has grown strongly in recent years. It will grow from $9.88 billion in 2024 to $10.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing cases of mental health conditions, a growing need for mental health therapeutics, widespread adoption of typical antipsychotics, an inflating application of cognitive behavioral therapy, and the prevalence of stress-inducing global and economic conditions.
The psychosis market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the rising prevalence of stress and associated risk factors, increasing mental health burdens due to lifestyle changes, rising government initiatives, the growing adoption of mindfulness-based interventions and therapy programs, and rising investments in mental health research and innovative treatments. Major trends in the forecast period include the introduction of novel drug therapies, advancements in diagnostic technologies, the introduction of innovative injectable drugs, the use of biomarkers, and the demand for personalized medicines.
Download Your Free Sample PDF:
Which key factors are driving the expansion of the psychosis industry?
The increasing cases of mental health conditions are expected to propel the growth of the psychosis market going forward. Mental health conditions are disorders that impact a person's mood, thinking, behavior, and overall mental well-being. The increasing cases of mental health conditions are due to rising stress levels, lifestyle changes, social isolation, economic pressures, and genetic predisposition. Psychosis treatment support patients suffering with mental health issues through early diagnosis, medical intervention, and specialized treatments, leading to increased use of antipsychotic medications and therapy options. For instance, in 2024, according to the National Alliance On Mental Illness, a US-based organization, among people in the U.S. aged 18-44, psychosis spectrum and mood disorders account for nearly 600,000 hospitalizations each year. Therefore, the increasing cases of mental health conditions are driving the growth of the psychosis market.
How is the psychosis market segmented by product, application, and end-user?
The psychosis market covered in this report is segmented –
1) By Product: Tablet, Capsule, Injection
2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types
3) By Distribution Channel: Online, Offline
4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users
Subsegments:
1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets
2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules
3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics
View The Full Market Report:
Which sustainability trends are emerging in the psychosis market?
Major companies operating in the psychosis market are focusing on developing advanced virtual reality (VR) psychological therapy to improve treatment outcomes through interactive and personalized mental health interventions. Virtual reality (VR) psychological therapy is a mental health treatment that immerses individuals in controlled, computer-generated environments to alleviate distress, enhance cognitive function, and improve social skills through guided interventions, offering a safe and effective approach to symptom management. For instance, in April 2022, OxfordVR, a US-based digital therapeutics company, launched gameChangeVR to guide patients through cognitive behavioral therapy (CBT) in immersive, virtual scenarios. The automated VR therapy, delivered over six weekly sessions, showed significant benefits, particularly for those with severe psychological challenges, improving their paranoia and overall quality of life. This technology has the potential to significantly increase access to effective mental health care, addressing the shortage of clinicians and offering a scalable solution for treating millions of patients with severe mental illness.
Which leading companies are dominating the psychosis market landscape?
Major companies operating in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics
Which geographic areas are expected to offer the highest growth opportunities in thepsychosis market?
North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Psychosis Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Psychosis Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment